A team of researchers from Canada has developed a class of compounds which may help eradicate a neglected tropical disease that is currently hard to kill in its chronic form.
The research was published ahead of print in Antimicrobial Agents and Chemotherapy.
Chagas disease or American trypanosomiasis, caused by Trypanosoma cruzi, affects about 18 million people living mostly in Latin America. The parasite is transmitted to humans by blood-sucking reduviid bugs, also known as kissing bugs due to their predilection for feeding on the faces of their victims. In the United States, Chagas disease is considered one of the neglected parasitic infections, a group of five parasitic diseases that have been targeted by CDC for public health action.
“While historically infection was largely confined to poor and rural populations in Central and South America, it has been emerging in the U.S., Canada, Europe, Japan, and Australia, due to immigration, and nonvectorial transmission is becoming a public health threat,” says Deborah Nicoll-Griffith of the Merck Frosst Centre for Therapeutic Research in Kirkland, Quebec, a researcher on the study. One 2005 estimate put the number of people infected within the U.S. at 300,000 (1/1000).
There are two phases of Chagas disease: the acute phase and the chronic phase. Both phases can be symptom free or life threatening. Left untreated the disease can lead to cardiac and digestive disorders, as the parasite burrows into the heart, esophagus and colon tissue where it causes damage over time.
The current standard of care, the drug benznidazole, has significant activity against the parasite during the acute phase, but is less effective once the disease becomes chronic.
Efforts to find new drugs focus on disrupting an enzyme, cruzipain, which the parasite uses for digestion, to produce other cellular machinery, to evade the host’s immune system, and to invade heart and gastrointestinal tissues.
Nicoll-Griffith and her colleagues identified two compounds known as reversible cysteine protease inhibitors that fit cruzipain like jigsaw puzzle pieces, jamming the enzyme. In the study, they tested the efficacy of the compounds in mice against that of benznidazole. While all treatment groups showed a marked reduction in parasite burden, in all tissues, the two experimental compounds had greater cure rates of acute infections (90% and 78%) compared to benznidazole (71%.)
The Latest on: Chagas Disease
via Google News
The Latest on: Chagas Disease
- Marking World Neglected Tropical Diseases Dayon January 18, 2021 at 4:00 pm
By Sharon AtienoIn gearing up for this year’s Neglected Tropical Diseases Day, on 30th January, the World Health Organization (WHO) is set to launch a new roadmap for the next decade.Ending the ...
- Marking World Neglected Tropical Disease Dayon January 18, 2021 at 4:00 pm
By Sharon AtienoIn gearing up for this year’s Neglected Tropical Disease Day, on 30th January, the World Health Organization (WHO) is set to launch a new roadmap for the next decade.Ending the neglect ...
- Accelerating the Development of a Therapeutic Vaccine for Human Chagas Diseaseon January 6, 2021 at 4:01 pm
The studies described above provide a strong preclinical foundation for accelerating the development of a therapeutic human vaccine for Chagas disease. The authors are currently working to produce ...
- Chagas Disease Surveillance Activities — Seven States, 2017on December 25, 2020 at 4:00 pm
Chagas disease, a potentially life-threatening disease caused by the protozoan parasite Trypanosoma cruzi, has become a concern in the United States as a result of human emigration from Latin ...
- Scorpion Venom Helps Treat Chagas Diseaseon December 25, 2020 at 12:10 pm
VmCT1, the antimicrobial peptide isolated from the venom of the scorpion Vaejovis mexicanus killed Trypanosoma cruzi, the parasite that causes Chagas disease, said researchers at the Federal ...
- Enhanced scorpion venom molecules can be used to treat Chagas diseaseon December 21, 2020 at 11:52 am
Chagas is considered a neglected disease by the World Health Organization (WHO). It is endemic in several countries, affecting some 8 million people worldwide and killing around 10,000 per year.
- Chagas Diseaseon December 20, 2020 at 4:01 pm
A new study examines local perceptions of Chagas disease in a region where the infectious agent is endemic. The results underline the need to take social and cultural factors into account in ...
- A blood-sucking, face-biting bug is spreading through the USon December 18, 2020 at 11:58 am
While kissing bug bites aren't dangerous, the insect can transmit a parasite that causes a serious but treatable condition called Chagas disease. In July 2018, a Delaware family in Kent County ...
- What is Tropical Medicineon December 18, 2020 at 3:11 am
he neglected tropical diseases (NTDs) are a group of 17 most common chronic parasitic and other infectious diseases, such as hookworm, schistosomiasis, river blindness, leishmaniasis and Chagas ...
- Metabolic State of a Parasite Influences Its Resistance to Drugson December 2, 2020 at 2:50 am
The study in cultures of human cells infected with Trypanosoma cruzi (T. cruzi), the parasite that causes Chagas disease, suggests that its metabolic state influences the effectiveness of azole drugs ...
via Bing News